![The European Medicines Agency still has a way to go towards clinical trial transparency - The Pharmaceutical Journal The European Medicines Agency still has a way to go towards clinical trial transparency - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/02/clinical-transparency-lack-of-european-medicines-agency-14-927x617.jpg)
The European Medicines Agency still has a way to go towards clinical trial transparency - The Pharmaceutical Journal
![Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency](https://www.ema.europa.eu/sites/default/files/chmp_statement_clinical_trials.jpg)
Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments | European Medicines Agency
![Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dd3ed348-79ec-42d9-8d3f-6fdc3aa7b3c2/gr1_lrg.jpg)
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy
![Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/19af1aea-f1c6-4663-8f82-bc7fdeb5f789/gr1_lrg.jpg)
Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit - European Journal of Cancer
![Transparency of clinical trials and good governance should be included in the EMA extended mandate | European Alliance for Responsible R&D and Affordable Medicines Transparency of clinical trials and good governance should be included in the EMA extended mandate | European Alliance for Responsible R&D and Affordable Medicines](https://medicinesalliance.eu/wp-content/uploads/2021/09/Screen-Shot-2021-09-14-at-14.16.57.png)
Transparency of clinical trials and good governance should be included in the EMA extended mandate | European Alliance for Responsible R&D and Affordable Medicines
EU Medicines Agency on Twitter: "‼️ Joint @EU_Health, #HMA, @EMA_News press briefing on new Clinical Trials Regulation will be broadcast live 🔴 today, 25 January, from 11:00 CET. #EMAPresser #ClinicalTrials 👉 https://t.co/yTddHobOXb
![EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN](https://metab.ern-net.eu/wp-content/uploads/2018/06/33841578_464265530653872_8714539216823910400_o-1024x576.png)
EMA and ERN Collaboration: How European Reference Networks can add value to clinical research - MetabERN
![European Medicines Agency - EORTC Workshop On Novel PRO And QoL Approaches In Cancer Clinical Research - Postponed - EORTC : EORTC European Medicines Agency - EORTC Workshop On Novel PRO And QoL Approaches In Cancer Clinical Research - Postponed - EORTC : EORTC](https://www.eortc.org/app/uploads/2020/02/EORTC_EMA_banner_900x400_2020-900x400.jpg)
European Medicines Agency - EORTC Workshop On Novel PRO And QoL Approaches In Cancer Clinical Research - Postponed - EORTC : EORTC
![EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | ERICA EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | ERICA](https://erica-rd.eu/wp-content/uploads/2021/12/EMA-webinar.png)
EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | ERICA
![EMA's Clinical Trials Information System (CTIS) goes live – EJP RD – European Joint Programme on Rare Diseases EMA's Clinical Trials Information System (CTIS) goes live – EJP RD – European Joint Programme on Rare Diseases](https://www.ejprarediseases.org/wp-content/uploads/2022/02/logo_ema2-e1643706581775.png)